NEW YORK (GenomeWeb News) – Fluidigm has raised $18.2 million through the private placement of an undisclosed number of shares, according to a filing with the US Securities and Exchange Commission.
The South San Francisco, Calif.-based firm is seeking to raise up to a total of $24.1 million from the offering, according to the SEC filing.
A Fluidigm spokesman confirmed the amount of money raised so far, but he could not provide any further details at this time.
Fluidigm President and CEO Gajus Worthington recently told GenomeWeb Daily News that the company intends to quadruple the size of its US sales staff to 60 people over the next two years. "It's clear that the market is there, the business is there, and now we really need to hire a large number of experienced sales operations folks in North America," he told GWDN.
The company had planned to go public last year, but was thwarted by the economic downturn and the stock market's nosedive in the fall of 2008. At the time, it had hoped to raise as much as $82 million to support its R&D and commercialization efforts.